Global (United States, European Union and China) Biosimulation Market Research Report 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biosimulation Revenue
• 1.4 Market by Type
  • 1.4.1 Global Biosimulation Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Molecular Simulation
  • 1.4.3 Clinical Trials
  • 1.4.4 Toxicity Prediction Software
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Biosimulation Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Scientific Research Institutions
  • 1.5.4 Government Department
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimulation Market Perspective (2015-2026)
• 2.2 Global Biosimulation Growth Trends by Regions
  • 2.2.1 Biosimulation Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biosimulation Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biosimulation Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biosimulation Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biosimulation Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimulation Players by Market Size
  • 3.1.1 Global Top Biosimulation Players by Revenue (2015-2020)
  • 3.1.2 Global Biosimulation Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biosimulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biosimulation Market Concentration Ratio
  • 3.2.1 Global Biosimulation Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biosimulation Revenue in 2019
• 3.3 Biosimulation Key Players Head office and Area Served
• 3.4 Key Players Biosimulation Product Solution and Service
• 3.5 Date of Enter into Biosimulation Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Biosimulation Historic Market Size by Type (2015-2020)
• 4.2 Global Biosimulation Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Biosimulation Market Size by Application (2015-2020)
• 5.2 Global Biosimulation Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biosimulation Market Size (2015-2020)
• 6.2 Biosimulation Key Players in North America (2019-2020)
• 6.3 North America Biosimulation Market Size by Type (2015-2020)
• 6.4 North America Biosimulation Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biosimulation Market Size (2015-2020)
• 7.2 Biosimulation Key Players in Europe (2019-2020)
• 7.3 Europe Biosimulation Market Size by Type (2015-2020)
• 7.4 Europe Biosimulation Market Size by Application (2015-2020)

8 China

• 8.1 China Biosimulation Market Size (2015-2020)
• 8.2 Biosimulation Key Players in China (2019-2020)
• 8.3 China Biosimulation Market Size by Type (2015-2020)
• 8.4 China Biosimulation Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biosimulation Market Size (2015-2020)
• 9.2 Biosimulation Key Players in Japan (2019-2020)
• 9.3 Japan Biosimulation Market Size by Type (2015-2020)
• 9.4 Japan Biosimulation Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biosimulation Market Size (2015-2020)
• 10.2 Biosimulation Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biosimulation Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biosimulation Market Size by Application (2015-2020)

11 India

• 11.1 India Biosimulation Market Size (2015-2020)
• 11.2 Biosimulation Key Players in India (2019-2020)
• 11.3 India Biosimulation Market Size by Type (2015-2020)
• 11.4 India Biosimulation Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biosimulation Market Size (2015-2020)
• 12.2 Biosimulation Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biosimulation Market Size by Type (2015-2020)
• 12.4 Central & South America Biosimulation Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Accelrys
  • 13.1.1 Accelrys Company Details
  • 13.1.2 Accelrys Business Overview
  • 13.1.3 Accelrys Biosimulation Introduction
  • 13.1.4 Accelrys Revenue in Biosimulation Business (2015-2020))
  • 13.1.5 Accelrys Recent Development
• 13.2 Certara
  • 13.2.1 Certara Company Details
  • 13.2.2 Certara Business Overview
  • 13.2.3 Certara Biosimulation Introduction
  • 13.2.4 Certara Revenue in Biosimulation Business (2015-2020)
  • 13.2.5 Certara Recent Development
• 13.3 Simulation Plus
  • 13.3.1 Simulation Plus Company Details
  • 13.3.2 Simulation Plus Business Overview
  • 13.3.3 Simulation Plus Biosimulation Introduction
  • 13.3.4 Simulation Plus Revenue in Biosimulation Business (2015-2020)
  • 13.3.5 Simulation Plus Recent Development
• 13.4 Dassault Systems SA
  • 13.4.1 Dassault Systems SA Company Details
  • 13.4.2 Dassault Systems SA Business Overview
  • 13.4.3 Dassault Systems SA Biosimulation Introduction
  • 13.4.4 Dassault Systems SA Revenue in Biosimulation Business (2015-2020)
  • 13.4.5 Dassault Systems SA Recent Development
• 13.5 Schrodinger
  • 13.5.1 Schrodinger Company Details
  • 13.5.2 Schrodinger Business Overview
  • 13.5.3 Schrodinger Biosimulation Introduction
  • 13.5.4 Schrodinger Revenue in Biosimulation Business (2015-2020)
  • 13.5.5 Schrodinger Recent Development
• 13.6 Advanced Chemistry Development
  • 13.6.1 Advanced Chemistry Development Company Details
  • 13.6.2 Advanced Chemistry Development Business Overview
  • 13.6.3 Advanced Chemistry Development Biosimulation Introduction
  • 13.6.4 Advanced Chemistry Development Revenue in Biosimulation Business (2015-2020)
  • 13.6.5 Advanced Chemistry Development Recent Development
• 13.7 Chemical Computing Group
  • 13.7.1 Chemical Computing Group Company Details
  • 13.7.2 Chemical Computing Group Business Overview
  • 13.7.3 Chemical Computing Group Biosimulation Introduction
  • 13.7.4 Chemical Computing Group Revenue in Biosimulation Business (2015-2020)
  • 13.7.5 Chemical Computing Group Recent Development
• 13.8 Entelos Holding Corporation
  • 13.8.1 Entelos Holding Corporation Company Details
  • 13.8.2 Entelos Holding Corporation Business Overview
  • 13.8.3 Entelos Holding Corporation Biosimulation Introduction
  • 13.8.4 Entelos Holding Corporation Revenue in Biosimulation Business (2015-2020)
  • 13.8.5 Entelos Holding Corporation Recent Development
• 13.9 Genedata AG
  • 13.9.1 Genedata AG Company Details
  • 13.9.2 Genedata AG Business Overview
  • 13.9.3 Genedata AG Biosimulation Introduction
  • 13.9.4 Genedata AG Revenue in Biosimulation Business (2015-2020)
  • 13.9.5 Genedata AG Recent Development
• 13.10 Physiomics PLC
  • 13.10.1 Physiomics PLC Company Details
  • 13.10.2 Physiomics PLC Business Overview
  • 13.10.3 Physiomics PLC Biosimulation Introduction
  • 13.10.4 Physiomics PLC Revenue in Biosimulation Business (2015-2020)
  • 13.10.5 Physiomics PLC Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer